XML 46 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Stock-Based Compensation.  
Schedule summarizing stock option activity under the 2001 Stock Plan, 2011 Stock Plan and 2015 Stock Plan

Stock Options

The following table summarizes stock option activity under the 2011 Stock Plan and 2015 Stock Plan:

    

Number of

    

    

Weighted-

    

 

shares

Weighted-

average

Aggregate

underlying

average

remaining

intrinsic

options

exercise price

contractual

value (in

(in thousands)

per share

    

life (in years)

thousands)

Outstanding at December 31, 2018

 

6,307

$

21.36

7.3

$

69,555

 

Granted

 

186

68.10

Replacement Awards

803

13.64

Exercised

 

(696)

21.53

33,132

Canceled/forfeited/expired

 

(17)

42.75

Outstanding at December 31, 2019

 

6,583

$

23.91

6.1

$

204,062

Granted

 

880

38.15

Exercised

 

(1,403)

14.42

50,093

Canceled/forfeited/expired

 

(76)

42.13

Outstanding at December 31, 2020

 

5,984

$

27.59

5.7

$

285,366

Granted

50

60.74

Adjustments to certain prior year grants

(47)

33.38

Exercised

(1,303)

20.07

68,162

Canceled/forfeited/expired

(142)

52.15

Outstanding at December 31, 2021

4,542

$

29.30

5.0

$

74,039

Vested and expected to vest at December 31, 2021

5,316

(i)  

$

22.92

3.8

$

119,428

Exercisable at December 31, 2021

3,942

$

27.39

4.5

$

70,336

(i)Included in the outstanding balance at December 31, 2021 are 276 performance-based options.
Schedule of the weighted-average assumptions used to estimate the fair value of options granted to employees

Year ended

 

December 31,

 

2021

2020

2019

 

Risk-free interest rate

    

0.98

%  

0.71

%  

2.17

Expected dividend yield

 

0.0

%  

0.0

%  

0.0

%

Expected volatility

 

43.4

%  

48.8

%  

46.8

%

Expected term (in years)

 

5.71

6.01

6.01

Schedule summarizing restricted stock unit activity

Weighted-

Number of

average

shares

grant date

    

(in thousands)

    

fair value

Unvested at December 31, 2019

695

$

54.40

Granted

674

33.69

Vested

(310)

55.96

Canceled/forfeited

(71)

39.03

Unvested at December 31, 2020

 

988

$

40.82

Granted

683

58.20

Vested

(360)

41.12

Canceled/forfeited

(126)

52.93

Unvested at December 31, 2021

1,185

(i)  

$

49.65

(i)Included in the unvested balance at December 31, 2021 are 176 performance-based RSU awards.
Schedule summarizing the allocation of stock-based compensation

The following table summarizes the allocation of stock-based compensation related to stock options and RSUs and includes Replacement Awards, as well as cash-settled stock options in the accompanying consolidated statements of operations (in thousands):

Year ended

 

December 31,

 

2021

2020

2019

 

    

Cost of sales

    

$

1,739

$

2,440

    

$

1,127

Selling, general & administrative

21,665

 

32,072

 

31,801

Research and development

6,742

 

8,793

 

6,553

Total

 

$

30,146

$

43,305

$

39,481

(i)Of the total stock-based compensation amount of $43.3 million as of December 31, 2020 above, $13.0 million related to the value attributable to the pre-combination services associated with Replacement Awards and a $(3.2) million fair value adjustment was recorded related to cash-settled stock options, and the remainder of the liability of $2.2 million related to the cash-settled options that was previously included in accrued liabilities was, as a result of the modification, reclassified to additional paid-in capital.
(ii)Of the total stock-based compensation amount of $39.5 million as of December 31, 2019 above, $4.5 million related to the value attributable to the pre-combination services associated with Replacement Awards and $3.1 million relates to cash-settled stock options included in accrued liabilities within the consolidated balance sheet.